The expression of NAMPT and the level of NAD+ are reduced in WAT during obesity, and NAMPT deficiency in adipocytes markedly alters the endocrine function of WAT and the insulin sensitivity [43,44,58]. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.